| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: mBiomics |
| Recipient: You |
| Company: Zola |
| Recipient: You |
|
| Honoraria |
| Company: Merck |
| Recipient: You |
| Company: ACM Biolabs |
| Recipient: You |
| Company: Clinical Care Options (CCO) |
| Recipient: You |
| Company: Gerson Lehrman Group (GLG) |
| Recipient: You |
| Company: Medical Learning Group |
| Recipient: You |
| Company: Xilio Therapeutics |
| Recipient: You |
| Company: Ascendis Pharma |
| Recipient: You |
| Company: Replimune |
| Recipient: You |
| Company: Immunocore |
| Recipient: You |
| Company: TriSalus Life Sciences |
| Recipient: You |
| Company: Arcus Biosciences |
| Recipient: You |
| Company: Regeneron |
| Recipient: You |
| Company: GlaxoSmithKline |
| Recipient: You |
| Company: Castle Biosciences |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Xilio Therapeutics |
| Recipient: You |
| Company: Gerson Lehrman Group |
| Recipient: You |
| Company: Clinical Care Options |
| Recipient: You |
| Company: ACM Bio |
| Recipient: You |
| Company: Ascendis Pharma |
| Recipient: You |
| Company: Replimmune |
| Recipient: You |
| Company: TriSalus Life Sciences |
| Recipient: You |
|
| Speakers' Bureau |
| Company: Castle Biosciences |
| Recipient: You |
|
| Research Funding |
| Company: Merck |
| Recipient: You |
| Company: Checkmate Pharmaceuticals |
| Recipient: You |
| Company: CellSight Technologies |
| Recipient: You |
| Company: GSK |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Arcus Biosciences |
| Recipient: You |
| Company: Zucero Therapeutics |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: Application No.: 63/124,231 |
| Recipient: You |
| Please describe: Enteric Microbiotype Signatures of Immune-related Adverse Events and Response in Relation to Anti-PD-1 Immunotherapy |
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|